Skip to main content Skip to footer

Value Cases in development

Diabetes Prevention

In October 2023, the IDA approved the Value Assessment for a digitally enabled programme designed to help individuals with prediabetes to reduce their weight and prevent the progression to type 2 diabetes.

A digital weight management and lifestyle programme, based on behaviour change methods, it will offer support from dietitians, nutritionists, and health coaches. Participants will engage in a 9-month programme aimed at achieving a 5% reduction in body weight. This reduction is expected to lead to lower BMI, blood pressure, and blood glucose levels, as well as increased physical activity and improved diet quality.

Chest X-Ray AI

in March 2024, the Innovation Design Authority approved the strategic case for implementing artificial intelligence (AI) to identify high-risk chest x-rays (CXRs).

The AI aims to flag high-risk CXR images in the lung cancer pathway, helping clinicians prioritise patients for CT scans. This could streamline diagnosis and treatment, improving patient outcomes.

Diabetes Remission

Following approval by the Innovation Design Authority, the Scottish Government announced funding (£4.5m) for the Digital Diabetes Programme in March 2025. This national programme is aimed at supporting individuals living with type 2 diabetes to reduce their weight and achieve remission. Over three years the programme will support 3,000 people recently diagnosed with type 2 diabetes and is expected to help around 40% of patients achieve remission from Type 2 Diabetes by the end of their first year in the programme. 

This programme, led by specialist dietitians and health coaches, will be delivered via a fully remote digital healthcare platform.

Ambulatory Electrocardiogram (aECG) Patch

In December 2024, the Innovations Design Authority (IDA) approved the Strategic Case for Ambulatory Electrocardiogram (aECG) Patch Monitors to move to Value Case. The Value Case will further explore the opportunity to enhance the current diagnosis to treatment pathway for atrial fibrillation (AF) using ECG patch technology.

This could improve patient experience, reduce diagnostic waiting times, improve time to treatment with the potential to prevent significant numbers of stroke and AF related heart complications.

This will in turn reduce demands on NHS Scotland.